<DOC>
	<DOCNO>NCT00630474</DOCNO>
	<brief_summary>Whether impaired nasal breathe contributes sleep related breathing disturbance know . Therefore , purpose study compare effect xylometazoline , drug decongests nasal mucosa apply locally , placebo term sleep nocturnal breathing daytime performance .</brief_summary>
	<brief_title>Nasal Decongestion Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Xylometazoline</mesh_term>
	<criteria>Obstructive sleep apnea syndrome ( excessive sleepiness , apnea/hypopnea index &gt; 10/h ) Chronic nasal congestion ( complaint impair nasal breathe interfered subjective sleep quality least 3 night per week least last 3 month ) Nasal surgery within last 6 month Current treatment nasal decongestant topical steroid Sleep disorder obstructive sleep apnea Internal medical psychiatric disorder interfere sleep</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>sleep apnea , rhinitis</keyword>
</DOC>